Novel Approach of Cyclodextrin-based Pharmaceutical Formulation
نویسندگان
چکیده
منابع مشابه
Formulation of Modified Microspheres Based on Cyclodextrin-Lactic Acid Polymers
Polymers, based on Poly L-lactic acid (L-PLA) and coupled with β-Cyclodextrin (β-CD), have been used for the preparation of microspheres for drug encapsulation. The strategy was based on the modification of the terminal carboxylic group of L-PLA (73.000) by coupling it with a β-CD in the presence of the peptide coupling agents: DCC/HOBT. The degree of functionalisation was found to be 80%. Char...
متن کاملPharmaceutical Engineering: Optimization of a Pharmaceutical Formulation
The effects of magnesium stearate (MgSt) and shear stress on flow properties and hydrophobicity are not well known. Blends with different concentrations of magnesium stearate and varying amounts of shear were tested using three different procedures: the FT4 Rheometer test, a tap density analyzer, and the Washburn method, to better understand the relation of lubricant concentration, amount of sh...
متن کاملCyclodextrin based nanosponges for pharmaceutical use: a review.
Nanosponges are a novel class of hyper-crosslinked polymer based colloidal structures consisting of solid nanoparticles with colloidal sizes and nanosized cavities. These nano-sized colloidal carriers have been recently developed and proposed for drug delivery, since their use can solubilize poorly water-soluble drugs and provide prolonged release as well as improve a drug's bioavailability by ...
متن کاملChitosan: a Novel Excipient in Pharmaceutical Formulation: a Review
Chitosan is a cationic natural polysaccharide which is derived from the chitin of crustaceans, with crabs and shrimp-shell wastes as its principal source. Its properties includes extent of deacetylation and the average molecular weight of polymer as well as low toxicity and good bioavailability make it a novel excipient in pharmaceutical formulation as a relatively new development. Together wit...
متن کاملPharmacokinetics of Injectable Beta – Cyclodextrin - Oridonin Inclusion Complex, A Novel Formulation of Oridonin in Wistar Rats
Aims: Oridonin is a new anti-tumor drug candidate with promising broad spectrum antitumor activity. The aim of the present study is to investigate the singleand repeated-dose pharmacokinetics of injectable beta-cyclodextrin-oridonin inclusion complexin rats. Materials and methods: Rats were given singleor multiple-dose (7 days) of injectable beta-cyclodextrin-oridonin inclusion complex (single-...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: YAKUGAKU ZASSHI
سال: 2012
ISSN: 0031-6903,1347-5231
DOI: 10.1248/yakushi.132.85